Velsera is a brand that connects healthcare and life sciences to unlock the true potential of precision medicine. Their mission is to foster a continuous flow of knowledge between researchers, scientists, and clinicians worldwide, leading to groundbreaking insights that significantly impact human health. By harnessing the power of AI and technology solutions, Velsera enables researchers and clinicians to leverage data and make it actionable.

Their innovative products and services accelerate research and development, democratize omics, and provide bedside analytics to improve patient outcomes. Velsera's value loop drives perpetual innovation by facilitating the seamless exchange of knowledge between the clinical realm and R&D. This iterative learning process informs diagnostics, translates research discoveries into practical applications, and fuels new breakthroughs.

From managing patient samples to aggregating clinical information and integrating diverse data sets, Velsera empowers precision R&D, improves drug discovery and clinical trials, and sets the standard for omics-based healthcare. Partnered with industry-leading companies and supported by Summa Equity, Velsera solidifies its position as the global provider of omics and insights in the field of precision health